BRIEF published on 11/08/2024 at 14:10, 13 days ago Moody’s Upgrades Elis to Investment-Grade Rating Financial Strength Moody's Credit Rating Elis Investment-grade
PRESS RELEASE published on 11/08/2024 at 14:05, 13 days ago Elis: Moody's upgrades Elis to investment-grade rating Elis upgraded to investment-grade "Baa3" credit rating by Moody’s indicating financial strength and growth potential. Company now rated investment-grade by major agencies Financial Strength Moody's Credit Rating Elis Investment-grade
BRIEF published on 10/11/2024 at 09:53, 1 month 10 days ago Crossing of threshold by Brasil Warrant Administraçao de Bens e Empresas Acquisition Of Shares Threshold Crossing Elis BWSA Current Strategy
BRIEF published on 10/10/2024 at 11:47, 1 month 11 days ago Elis: Status of Shares and Voting Rights as of September 30, 2024 Share Capital Voting Rights Actions Financial Press Release Elis
PRESS RELEASE published on 10/10/2024 at 11:42, 1 month 11 days ago Elis: Disclosure of the number of shares forming the capital and of the total number of voting rights as of 30 09 2024 Disclosure of the number of shares forming the capital and total voting rights as of 30 September 2024 by Elis SA. Details can be found on www.elis.com Voting Rights Shares Investor Relations Disclosure Elis SA
BRIEF published on 10/04/2024 at 15:10, 1 month 16 days ago Elis Ends Discussions with Vestis and UniFirst Organic Growth US Market Circular Economy Financial Discipline Elis
PRESS RELEASE published on 10/04/2024 at 15:05, 1 month 16 days ago Elis: Termination of discussions with Vestis and UniFirst Elis terminates discussions with Vestis and UniFirst regarding a potential entry into the US market due to financial considerations, remains focused on organic growth and value-creating acquisitions Acquisitions Termination US Market Discussions Elis
BRIEF published on 09/08/2024 at 16:48, 2 months 12 days ago Elis organizes a webcast as part of a non-deal roadshow Investors Webcast Strategy Roadshow Elis
PRESS RELEASE published on 09/08/2024 at 16:43, 2 months 12 days ago Elis to host a webcast as part of non-deal roadshow Elis to host investor roadshow with webcast and Q&A session featuring management team. Presentation available on corporate website. Details in press release Management Team Webcast Elis Investor Roadshow Corporate Website
BRIEF published on 09/05/2024 at 11:16, 2 months 16 days ago Elis: Number of shares and voting rights as of August 31, 2024 Share Capital Voting Rights Actions 2024 Elis
Published on 11/21/2024 at 14:00, 18 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 18 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 18 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 13:30, 48 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 12:35, 1 hour 42 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 2 hours 3 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 20 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 58 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 33 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 33 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
